Applied Genetic Technologies reported $70.53M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
Avrobio Inc AVRO:US 170.92M 28.22M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Life Technologies LIFE:US $ 103.12M 10.45M
Ophthotech OPHT:US $ 350.97M 36.52M